Nations Financial Group Inc. IA ADV Cuts Stock Position in The Procter & Gamble Company (NYSE:PG)

Nations Financial Group Inc. IA ADV lessened its stake in The Procter & Gamble Company (NYSE:PGFree Report) by 6.1% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 26,471 shares of the company’s stock after selling 1,706 shares during the period. Nations Financial Group Inc. IA ADV’s holdings in Procter & Gamble were worth $3,879,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds also recently added to or reduced their stakes in PG. Norges Bank acquired a new position in Procter & Gamble in the fourth quarter valued at approximately $3,956,117,000. Cerity Partners LLC increased its position in shares of Procter & Gamble by 106.2% in the fourth quarter. Cerity Partners LLC now owns 6,134,455 shares of the company’s stock valued at $898,943,000 after buying an additional 3,159,796 shares in the last quarter. Wellington Management Group LLP increased its position in shares of Procter & Gamble by 9.4% in the third quarter. Wellington Management Group LLP now owns 35,608,913 shares of the company’s stock valued at $5,193,916,000 after buying an additional 3,047,557 shares in the last quarter. International Assets Investment Management LLC increased its position in shares of Procter & Gamble by 13,850.3% during the fourth quarter. International Assets Investment Management LLC now owns 2,747,379 shares of the company’s stock worth $402,601,000 after purchasing an additional 2,727,685 shares in the last quarter. Finally, Assenagon Asset Management S.A. increased its position in shares of Procter & Gamble by 235.8% during the fourth quarter. Assenagon Asset Management S.A. now owns 3,231,032 shares of the company’s stock worth $473,475,000 after purchasing an additional 2,268,805 shares in the last quarter. Hedge funds and other institutional investors own 65.77% of the company’s stock.

Insider Activity

In related news, insider Balaji Purushothaman sold 28,369 shares of the firm’s stock in a transaction that occurred on Tuesday, April 23rd. The stock was sold at an average price of $161.49, for a total transaction of $4,581,309.81. Following the transaction, the insider now owns 11,507 shares in the company, valued at approximately $1,858,265.43. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. In related news, insider Balaji Purushothaman sold 28,369 shares of the firm’s stock in a transaction that occurred on Tuesday, April 23rd. The stock was sold at an average price of $161.49, for a total transaction of $4,581,309.81. Following the transaction, the insider now owns 11,507 shares in the company, valued at approximately $1,858,265.43. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CEO Sundar G. Raman sold 31,924 shares of the firm’s stock in a transaction that occurred on Monday, May 20th. The stock was sold at an average price of $166.95, for a total value of $5,329,711.80. Following the transaction, the chief executive officer now owns 19,042 shares in the company, valued at approximately $3,179,061.90. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 155,320 shares of company stock worth $25,535,744. 0.17% of the stock is currently owned by insiders.

Procter & Gamble Stock Down 0.1 %

NYSE PG traded down $0.16 during trading hours on Friday, hitting $165.33. 3,820,090 shares of the company were exchanged, compared to its average volume of 5,487,361. The company has a 50 day moving average of $161.83 and a two-hundred day moving average of $155.99. The company has a quick ratio of 0.48, a current ratio of 0.69 and a debt-to-equity ratio of 0.49. The Procter & Gamble Company has a 52-week low of $141.45 and a 52-week high of $168.54. The firm has a market cap of $390.20 billion, a price-to-earnings ratio of 27.01, a PEG ratio of 3.36 and a beta of 0.43.

Procter & Gamble (NYSE:PGGet Free Report) last issued its quarterly earnings results on Friday, April 19th. The company reported $1.52 earnings per share for the quarter, topping the consensus estimate of $1.42 by $0.10. Procter & Gamble had a return on equity of 33.91% and a net margin of 18.00%. The company had revenue of $20.20 billion for the quarter, compared to the consensus estimate of $20.43 billion. During the same quarter in the prior year, the business earned $1.37 EPS. Procter & Gamble’s revenue was up .6% on a year-over-year basis. Equities research analysts anticipate that The Procter & Gamble Company will post 6.55 earnings per share for the current year.

Procter & Gamble Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, May 15th. Stockholders of record on Friday, April 19th were issued a $1.0065 dividend. The ex-dividend date of this dividend was Thursday, April 18th. This represents a $4.03 dividend on an annualized basis and a dividend yield of 2.44%. This is an increase from Procter & Gamble’s previous quarterly dividend of $0.94. Procter & Gamble’s dividend payout ratio is presently 65.85%.

Wall Street Analysts Forecast Growth

PG has been the subject of several research reports. Jefferies Financial Group boosted their price target on Procter & Gamble from $175.00 to $182.00 and gave the stock a “buy” rating in a research report on Monday, April 22nd. The Goldman Sachs Group assumed coverage on Procter & Gamble in a research note on Friday, March 1st. They set a “neutral” rating and a $168.00 price objective on the stock. Truist Financial raised Procter & Gamble from a “hold” rating to a “buy” rating and boosted their price objective for the stock from $160.00 to $175.00 in a research note on Monday, March 11th. Barclays boosted their price objective on Procter & Gamble from $168.00 to $170.00 and gave the stock an “overweight” rating in a research note on Tuesday, April 23rd. Finally, Argus boosted their price objective on Procter & Gamble from $180.00 to $185.00 and gave the stock a “buy” rating in a research note on Thursday, April 25th. Seven analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. Based on data from MarketBeat, Procter & Gamble has an average rating of “Moderate Buy” and a consensus target price of $169.76.

View Our Latest Analysis on Procter & Gamble

About Procter & Gamble

(Free Report)

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.

Featured Stories

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.